This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08342/identifier/pdb/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08342/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08342/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08342/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08342
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB08342 n13:DB08342
dcterms:title
S-PALMITOYL-L-CYSTEINE
adms:identifier
n6:P1L n7:46937142 n8:DB08342 n9:99444813
n3:IUPAC-Name
n4:271B4EDD-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4EE3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4EE2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4EDF-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4EE0-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4EE1-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4EDB-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4EDC-363D-11E5-9242-09173F13E4C5 n4:271B4ED9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4EDA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4EE9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4EEA-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4EE4-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4EE5-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4EE7-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4EE6-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4EE8-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4EEF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4EF1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4EF2-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4EEE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4EED-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4EF0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4EDE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4EEB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4EEC-363D-11E5-9242-09173F13E4C5